PATIENT POPULATION. Patient population served will include: Adults Pediatrics Both adult and pediatrics Service/clinic setting: (example: BMT, CVTICU, GI, Family Medicine, etc.)
PATIENT POPULATION. Ages/Ratio: Adult Diagnoses: Anxiety. Depression. SMI. PTSD. Schizophrenia. Bi-Polar. Chronic & Persistently Mentally Ill. Referral Sources: How Patients are Seen (phone, video from home, video from clinic, etc.): Languages: None
PATIENT POPULATION. BioForm expects to implement standard inclusion and exclusion criteria to screen a population of evaluable patients for this study. **** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
PATIENT POPULATION. We identified 99 consecutive new referrals to the local interstitial lung disease unit who did not receive a diagnosis of IPF. There were 56 patients excluded: established diagnosis of CTD at the time of referral (n=23), presentation HRCT or PFTs not available (HRCT unavailable, n=20, PFTs unavailable, n=1), DLco<30% predicted (n=9), referral not for suspected ILD (n=8). The remaining 38 patients were included in the study. We identified 58 consecutive new referrals to the local interstitial lung disease unit who received a diagnosis of IPF. There were 36 patients excluded: presentation HRCT or PFTs not available (n=17), DLco<30% predicted (n=19). The remaining 22 patients were included in the study. Therefore, the total cohort was made up of 60 patients (Figure A1). Patient diagnoses (following evaluation at the Royal Brompton Hospital, UK) are shown in the Table A4. Five patients required surgical lung biopsy. Three of these were diagnosed as IPF, one as pulmonary alveolar proteinosis and one as obliterative bronchiolitis. Vital status was known for all patients at the end of the study period. There were 26/60 (43·4%) deaths at the end of the study period. 16/22 (72.7%) IPF cases died at the end of the study period. Mean follow-up period for IPF and non-IPF cases were 1246.0 days and 1646.0 days respectively. Physician Survey
PATIENT POPULATION. On average how many patients are seen EACH DAY in your practice? Less than 10 21-30 Greater than 30 Age range: Please indicate approximate percentages for all of the following that apply: Pediatric Adult <1 yr % 18-49 yrs % 1-12 yrs % 50-64 yrs % 13-17 yrs % ≥65 yrs % Please check ALL of the services you provide to your patients. Preventive Care Visits Acute/Urgent Care Visits Chronic Care Visits Emergency Medicine Gynecologic Care Visits Prenatal Medicine Obstetrics Nursing Home Surgical Care Pre-operative Care Post-operative Care Do you serve any special populations? Yes No If yes, please specify. Approximate percentage of patients who are: Medicare Medicaid Uninsured Student Experience How many students does the practice anticipate being able to accept PER YEAR for five-week rotations: Note: This is a non-binding estimate that supports program planning and development. Student will be provided opportunities to (check all that apply): Apply didactic knowledge to patient care Obtain medical histories Provide patient education Access the medical record Document in the medical record Provide oral patient presentations Formulate a differential diagnosis Develop, suggest and discuss diagnostic studies Develop, suggest therapeutic management plans Describe rationale for decisions about patient care Perform physical examinations Assist with/perform clinical procedures Assist in surgery Perform hospital rounds Perform nursing home rounds Other (please list): Additional Information Safety and security policies are available to students Yes No Security personnel are on site Yes No Phone # Parking available Yes No Cost/day Physical facilities allow student integration Yes No Preceptor able to provide adequate supervision Yes No Internet access available Yes No Please note any instructions for students, including all forms and requirements that need to be completed before their arrival and who they should contact prior to their arrival. Common considerations are background checks, drug screening, immunization documentation, HIPAA training at site, site-specific ID badge: Faculty Signature Date Title Preceptor Profile Primary Preceptor Name Title Phone Email Current License(s): Profession State License # Exp Current Board Certification: (For PA preceptors, please list supervising physician board certification) Board Specialty Exp If not Board Certified please state area of specialty Total number of years in practice: Education: Medical...
PATIENT POPULATION. For the present study, we selected subjects who had representative EUS-nCLE videos and a definitive histopathologic diagnosis of the most prevalent PCLs (IPMN, MCN, SCA, pseudocyst, SPN, cystic-NET). A total of 76 subjects fulfilled eligibility criteria and were included.
PATIENT POPULATION. Patient population served will include: (example: BMT Service, CVTICU Service, Adult GI Clinic, Family Medicine, etc.)
PATIENT POPULATION. The patient population is reasonably expected to consist of athletes for scholastic, amateur, collegiate, and professional teams and organizations under contract with AT Direct Sports Medicine, LLC; individuals otherwise participating in athletic events covered by AT Direct Sports Medicine, LLC, and its employed or contracted athletic trainers; and patients referred by the Physician to the Athletic Trainer for appropriate treatment.
PATIENT POPULATION. Patients are identified by searching the Emory electronic medical record system (Powerchart) that includes data on all patients followed at Emory University Hospitals. We reviewed the electronic charts of all patients admitted to the Emory Hospitals age ≥ 18 with primary diagnosis of worsening HF since January 2012. First consecutive eligible 100 subjects that had an all cause 30-day readmission are included in analysis for the study. The data in regards to patients demography, cause of admission, treatment and discharge at the time of admission, prior admissions and presence of comorbid conditions like diabetes, hypertension, Kidney disease, COPD, Ejection Fraction (EF) are collected and analyzed for preventable vs non preventable causes of readmission . Data Acquisition and Storage: Data was collected using the Emory electronic medical record (Powerchart). Patients admitted at Emory University Hospitals with primary diagnosis of HF are screened and the first 100 patients that had all cause 30-day readmission are identified and are included in the study. Data collected from Powerchart also included demographic factors, cause of admission, treatment and discharge at the time of admission, prior admissions and presence of comorbid conditions like diabetes, hypertension, Kidney disease, COPD, Ejection Fraction (EF), date of initial admission, date of readmission. Patients with all cause 30-day readmission were analyzed for their cause for readmission. The preventable causes for this study included inadequate treatment during the prior hospitalization, inadequate discharge plan and follow up and inadequate treatment of the comorbid conditions that might have precipitated the readmission. The non-preventable causes included unavoidable progression of chronic disease, patient’s non-compliance to diet and drugs due to socio economic and psychological factors like insurance, depression and lack of social support. All stored data is encrypted and organized with the use of a coding system in an excel spreadsheet. The excel spread sheet was stored in a shared drive that had restricted access with user id and password and also in an encrypted computer. Protection of Human Subjects: The study was conducted after approval of Emory University Institutional Review Board (IRB). The study qualified for a complete HIPAA waiver from Emory IRB because the study is a retrospective chart review study. Children (under the age of 18 years old) are not included in the study. This ...
PATIENT POPULATION. This collaborative practice agreement will apply to all patients referred to PHARMACIST, RPh by PHYSICIAN, MD. It will be understood that all such patients referred to PHARMACIST, RPh will have an established physician-patient relationship with PHYSICIAN, MD and that the referred patient requires LAIA treatment.
